1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd. NSE: BIOCON | BSE: 532523
Mid-range Performer
Download real time
348.35 -4.90 (-1.39%)
1.8M
NSE+BSE Volume

NSE 29 Aug, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
US FDA Approval
Biocon receives US FDA tentative approval for Sitagliptin Tablets, with a market size of $6.9 bn See details